Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dementia
Pharma
Axsome's Auvelity wins FDA expansion for Alzheimer's agitation
Axsome Therapeutics has gained FDA approval for its first-in-class Auvelity to treat agitation associated with Alzheimer’s disease.
Kevin Dunleavy
May 1, 2026 11:42am
Cognito partners with nonprofit to drop the term ‘dementia’
Apr 8, 2026 10:11am
Lilly backs study to improve disease representation in media
Mar 20, 2025 3:35pm
Otsuka adds kid-friendly resources to dementia caregiver toolbox
Mar 7, 2025 1:30pm
PAHO kicks off educational campaign to destigmatize dementia
Sep 5, 2024 11:53am
Lundbeck, Otsuka dial down the drama for Rexulti agitation ad
Oct 13, 2023 9:45am
